 Alefacept is a new anti-psoriatic drug within the group of the so-called biologics. In about 30 of patients alefacept induces a more than 75 improvement of psoriasis after a 12-week treatment period. The start of anti-psoriatic effect by alefacept is delayed, however improvement of psoriatic lesions outlasts the end of alefacept treatment. 